DI SCALA, GERARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.168
EU - Europa 1.341
AS - Asia 743
SA - Sud America 101
AF - Africa 40
OC - Oceania 5
Totale 4.398
Nazione #
US - Stati Uniti d'America 2.142
RU - Federazione Russa 644
SG - Singapore 226
IT - Italia 210
CN - Cina 163
HK - Hong Kong 149
IE - Irlanda 125
SE - Svezia 95
BR - Brasile 80
KR - Corea 74
PL - Polonia 72
FR - Francia 43
DE - Germania 39
VN - Vietnam 36
CH - Svizzera 34
FI - Finlandia 31
IN - India 30
CI - Costa d'Avorio 24
JO - Giordania 23
GB - Regno Unito 22
CA - Canada 11
ID - Indonesia 9
MA - Marocco 8
AR - Argentina 7
EC - Ecuador 7
NL - Olanda 7
MX - Messico 6
AT - Austria 5
IQ - Iraq 5
AU - Australia 4
ES - Italia 4
PE - Perù 4
UA - Ucraina 4
DO - Repubblica Dominicana 3
JP - Giappone 3
SA - Arabia Saudita 3
TR - Turchia 3
ZA - Sudafrica 3
AL - Albania 2
BD - Bangladesh 2
IR - Iran 2
KE - Kenya 2
KH - Cambogia 2
MY - Malesia 2
PA - Panama 2
PH - Filippine 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BB - Barbados 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RO - Romania 1
TN - Tunisia 1
Totale 4.398
Città #
Santa Clara 560
Ashburn 253
Fairfield 171
Singapore 139
Dublin 125
Hong Kong 120
Chandler 110
Seattle 84
Houston 78
Woodbridge 76
Seoul 73
Warsaw 72
Lawrence 53
Altamura 52
Beijing 52
Cambridge 52
Wilmington 51
Florence 46
Buffalo 45
Moscow 42
Los Angeles 35
Bern 33
Princeton 30
Boston 29
New York 29
Paris 28
Abidjan 24
Ann Arbor 22
Mumbai 22
Dallas 20
Munich 19
Shanghai 19
San Jose 18
Hefei 17
Helsinki 15
Rome 14
Boardman 13
Kent 12
San Diego 11
São Paulo 11
Turku 11
The Dalles 10
Jakarta 9
Clifton 8
Bologna 7
Brooklyn 7
Casablanca 7
Falls Church 7
Hanoi 7
Medford 7
Redwood City 7
Dong Ket 6
Ho Chi Minh City 6
Milan 6
Bari 5
Belo Horizonte 5
Chicago 5
Lappeenranta 5
Norwalk 5
Orem 5
Phoenix 5
Stockholm 5
Vienna 5
Denver 4
Frankfurt am Main 4
Guangzhou 4
Hillsboro 4
Jinan 4
London 4
Melbourne 4
Montreal 4
Napoli 4
Washington 4
Baghdad 3
Chennai 3
Guayaquil 3
Haiphong 3
Padova 3
Redmond 3
Rieti 3
Taiyuan 3
Tokyo 3
Toronto 3
Yubileyny 3
Amman 2
Andover 2
Basra 2
Biên Hòa 2
Brasília 2
Capannori 2
Castelliri 2
Charlotte 2
Concord 2
Contagem 2
Council Bluffs 2
Düsseldorf 2
Elk Grove Village 2
Guarulhos 2
Jundiaí 2
Lima 2
Totale 2.930
Nome #
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 236
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 210
Practice parameters for sublingual immunotherapy 186
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 184
Intravenous immunoglobulin therapy: a snapshot for the internist. 176
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 162
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 161
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 157
The Presence of Uveitis Is Associated With a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 156
Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus 155
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 152
Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis 149
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 144
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 141
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study 141
Predictors of Sustained Clinical Response in Patients With Behçet's Disease-Related Uveitis Treated With Infliximab and Adalimumab 137
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 135
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 133
Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role 123
Vascular Behçet's syndrome: an update 121
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 121
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts 119
Different Drug Survival of First Line Tumour Necrosis Factor Inhibitors in Radiographic and Non-Radiographic Axial Spondyloarthritis: A Multicentre Retrospective Survey 119
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 118
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis 116
Prompt Clinical Response to Secukinumab in Patients With Axial Spondyloarthritis: Real Life Observational Data From Three Italian Referral Centers 108
Clinical profile and evolution of patients with juvenile-onset Behçet’s syndrome over a 25-year period: insights from the AIDA network 104
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 103
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study 100
Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial 96
Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4) 93
Subclinical and Clinical Atherosclerosis in Rheumatoid Arthritis: Results From the 3-year, Multicentre, Prospective, Observational GIRRCS (Gruppo Italiano Di Ricerca in Reumatologia Clinica E Sperimentale) Study 90
Totale 4.446
Categoria #
all - tutte 14.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 0 12 13 36 25 23 14
2021/2022235 1 8 32 12 2 12 3 30 14 10 47 64
2022/2023595 54 164 20 14 30 88 71 29 62 8 17 38
2023/2024283 12 24 37 19 24 40 16 53 4 18 15 21
2024/20251.650 61 180 76 299 488 175 39 79 82 57 70 44
2025/2026950 200 206 129 133 184 75 23 0 0 0 0 0
Totale 4.446